CLINICAL OUTCOMES FROM VENETOCLAX BASED THERAPY IN PATIENTS WITH RELAPSED/REFRACTORY B‐CELL LYMPHOMAS. (12th June 2019) - Lewis, K.L.; Dowling, M.; Bavishi, K.; Øvlisen, A.K.; Hamad, N.; Choi, P.; Grigg, A.; P'Ng, S.; Filshie, R.; Ritchie, D.S.; Bilmon, I.; Prince, H.M.; et al.